Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials

Main Article Content

A Blauvelt
A Armstrong
P Rich
R Kisa
A Guana
X Meng
K Callis Duffin

Keywords

psoriasis, secukinumab, clinical trial

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Novartis.

 

Copyright 2018 SKIN